Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Amivantamab Plus Lazertinib Versus Osimertinib in First-Line EGFR-mutant Advanced Non-Small Cell Lung Cancer with Biomarkers of High-Risk Disease: a Secondary Analysis from MARIPOSA
E. Felip,B. C. Cho, V Gutierrez,A. Alip,B. Besse, S. Lu,A. I. Spira,N. Girard,R. Califano,S. M. Gadgeel,J. C-H. Yang, S. Yamamoto, K. Azuma,Y. J. Kim, K. -H. Lee,P. Danchaivijitr, C. G. Ferreira,Y. Cheng,M. A. N. Sendur,G. -C. Chang, C. -C. Wang, K. Prabhash, Y. Shinno, D. Stroyakovskiy, L. Paz-Ares, J. R. Rodriguez-Cid, C. Martin, M. R. G. Campelo, H. Hayashi, D. Nguyen, P. Tomasini, M. Gottfried, C. Dooms, A. Passaro, M. Schuler, A. C. Z. Gelatti, S. Owen, K. Perdrizet, S. -H. I. Ou, J. C. Curtin, J. Zhang, M. Gormley, T. Sun, A. Panchal, M. Ennis, E. Fennema, J. M. Bauml, M. Daksh, S. Sethi, S. -H. Lee
ANNALS OF ONCOLOGYno. 9 (2024): 805-816
Cited0Views0WOSBibtex
0
0
74P Five-year survival outcomes of camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic NSCLC: A phase II study
J-J. Yang, C. Huang, Y. Fan, H. Pan,J. Feng, L. Jiang, X. Li,X-Q. Liu,J-P. Xiong,Y. Zhao,Y. Cheng, R. Ma, J. Wang, Y. Wang,Y-H. Liu, D. Lin, X. Li, X. Ma, W. Shi,Y-L. Wu
ESMO Open (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 152

#Citation: 3116

H-Index: 23

G-Index: 55

Sociability: 7

Diversity: 2

Activity: 43

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn